If it were up to me, it’s unlikely I would be sitting down to write about my life with chronic…
On May 8, pharmaceutical company Gilead quietly announced that it will relinquish its exclusive patent on Truvada for HIV pre-exposure…
The fight for universal access to PrEP medication for HIV prevention was picked up by Vermont Senator and presidential hopeful…
It's been less than two weeks since the US Department of Justice joined a string of lawsuits against Indivior—the maker…
On April 16, the Drug Enforcement Administration (DEA) launched its latest punishment-driven, treatment-inflected response to the opioid-involved overdose crisis in…
In the lucrative but hit-and-miss opioid use disorder treatment field, buprenorphine is one medication that has demonstrated outstanding efficacy. It’s…
To accompany Alison Knopf's April 16 article about buprenorphine in light of federal charges against Suboxone manufacturer Indivior, Filter obtained…
Museums around the world, from New York City's Guggenheim to London's Tate Modern, have begun refusing donations from the Sackler family,…
On March 5, the US Food and Drug Administration (FDA) approved the prescription treatment Spravato (esketamine), an intranasal spray medicine…
Material living conditions are overall better in today’s world than during any time in history. Worldwide life expectancies are higher…